Skip to content 
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue. In addition, the company offers peripheral nerve tissue recovery and acquisition, and testing, as well as donor medical review and release, debridement and other processing steps, packaging, and sterilization. It provides its products to hospitals, surgery centers and military hospitals, calling on surgeons, including plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and certain oral and maxillofacial surgeons through independent in-country distributors. The company is headquartered in Alachua, Florida. more
| Time Frame | AXGN | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 10.51% | -2.67% | -1.29% |
| 1-Month Return | -4.75% | -2.18% | -2.25% |
| 3-Month Return | 7.71% | -0.48% | -1.84% |
| 6-Month Return | 92.2% | 9.4% | 2.89% |
| 1-Year Return | 85.36% | 4.65% | 21.66% |
| 3-Year Return | 328.82% | 21.98% | 75.67% |
| 5-Year Return | 54.94% | 33.67% | 71.9% |
| 10-Year Return | 528.21% | 122.85% | 234.46% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 127.36M | 138.58M | 159.01M | 187.34M | 225.21M | [{"date":"2021-12-31","value":56.55,"profit":true},{"date":"2022-12-31","value":61.54,"profit":true},{"date":"2023-12-31","value":70.61,"profit":true},{"date":"2024-12-31","value":83.18,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Cost of Revenue | 22.93M | 29.77M | 37.14M | 45.36M | 57.85M | [{"date":"2021-12-31","value":39.64,"profit":true},{"date":"2022-12-31","value":51.46,"profit":true},{"date":"2023-12-31","value":64.2,"profit":true},{"date":"2024-12-31","value":78.4,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Profit | 104.43M | 108.81M | 121.87M | 141.98M | 167.35M | [{"date":"2021-12-31","value":62.4,"profit":true},{"date":"2022-12-31","value":65.02,"profit":true},{"date":"2023-12-31","value":72.82,"profit":true},{"date":"2024-12-31","value":84.84,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Margin | 81.99% | 78.51% | 76.64% | 75.79% | 74.31% | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.76,"profit":true},{"date":"2023-12-31","value":93.47,"profit":true},{"date":"2024-12-31","value":92.43,"profit":true},{"date":"2025-12-31","value":90.63,"profit":true}] |
| Operating Expenses | 129.84M | 138.52M | 143.33M | 145.26M | 175.20M | [{"date":"2021-12-31","value":74.11,"profit":true},{"date":"2022-12-31","value":79.06,"profit":true},{"date":"2023-12-31","value":81.81,"profit":true},{"date":"2024-12-31","value":82.91,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Operating Income | (25.42M) | (29.71M) | (21.46M) | (3.29M) | (7.85M) | [{"date":"2021-12-31","value":-2541600000,"profit":false},{"date":"2022-12-31","value":-2970700000,"profit":false},{"date":"2023-12-31","value":-2146200000,"profit":false},{"date":"2024-12-31","value":-328700000,"profit":false},{"date":"2025-12-31","value":-784900000,"profit":false}] |
| Total Non-Operating Income/Expense | (2.92M) | 135.00K | (1.21M) | (14.88M) | (15.56M) | [{"date":"2021-12-31","value":-2166.67,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-893.33,"profit":false},{"date":"2024-12-31","value":-11024.44,"profit":false},{"date":"2025-12-31","value":-11522.96,"profit":false}] |
| Pre-Tax Income | (26.98M) | (28.95M) | (21.72M) | (9.96M) | (15.70M) | [{"date":"2021-12-31","value":-2698500000,"profit":false},{"date":"2022-12-31","value":-2894800000,"profit":false},{"date":"2023-12-31","value":-2171600000,"profit":false},{"date":"2024-12-31","value":-996400000,"profit":false},{"date":"2025-12-31","value":-1570300000,"profit":false}] |
| Income Taxes | 1.08M | (1.61M) | 5.39M | - | - | [{"date":"2021-12-31","value":20.02,"profit":true},{"date":"2022-12-31","value":-29.95,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income After Taxes | (28.06M) | (27.34M) | (27.10M) | - | - | [{"date":"2021-12-31","value":-2806300000,"profit":false},{"date":"2022-12-31","value":-2733500000,"profit":false},{"date":"2023-12-31","value":-2710110500,"profit":false},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | (26.98M) | (28.95M) | (23.24M) | (9.96M) | (15.70M) | [{"date":"2021-12-31","value":-2698500000,"profit":false},{"date":"2022-12-31","value":-2894800000,"profit":false},{"date":"2023-12-31","value":-2323800000,"profit":false},{"date":"2024-12-31","value":-996400000,"profit":false},{"date":"2025-12-31","value":-1570300000,"profit":false}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | (26.98M) | (28.95M) | (21.72M) | (9.96M) | (15.70M) | [{"date":"2021-12-31","value":-2698500000,"profit":false},{"date":"2022-12-31","value":-2894800000,"profit":false},{"date":"2023-12-31","value":-2171600000,"profit":false},{"date":"2024-12-31","value":-996400000,"profit":false},{"date":"2025-12-31","value":-1570300000,"profit":false}] |
| EPS (Diluted) | (0.34) | (0.30) | (0.18) | 0.13 | 0.29 | [{"date":"2021-12-31","value":-117.24,"profit":false},{"date":"2022-12-31","value":-103.45,"profit":false},{"date":"2023-12-31","value":-62.07,"profit":false},{"date":"2024-12-31","value":44.83,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| AXGN | |
|---|---|
| Cash Ratio | 1.51 |
| Current Ratio | 5.11 |
| Quick Ratio | 3.31 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| AXGN | |
|---|---|
| ROA (LTM) | -2.31% |
| ROE (LTM) | -13.49% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| AXGN | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.42 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.58 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| AXGN | |
|---|---|
| Trailing PE | NM |
| Forward PE | 147.06 |
| P/S (TTM) | 7.07 |
| P/B | 11.79 |
| Price/FCF | 889 |
| EV/R | 6.86 |
| EV/Ebitda | 3048.65 |
| PEG | 99.04 |
Axogen Inc (AXGN) share price today is $31.915
Yes, Indians can buy shares of Axogen Inc (AXGN) on Vested. To buy
Yes, you can purchase fractional shares of Axogen Inc (AXGN) via the Vested app. You can start investing in Axogen Inc (AXGN) with a minimum investment of $1.
You can invest in shares of Axogen Inc (AXGN) via Vested in three simple steps:
The 52-week high price of Axogen Inc (AXGN) is $36. The 52-week low price of Axogen Inc (AXGN) is $9.22.
The price-to-earnings (P/E) ratio of Axogen Inc (AXGN) is
The price-to-book (P/B) ratio of Axogen Inc (AXGN) is 11.79
The dividend yield of Axogen Inc (AXGN) is 0.00%
The market capitalization of Axogen Inc (AXGN) is $1.68B
The stock symbol (or ticker) of Axogen Inc is AXGN
Consider the share price of Axogen Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Axogen Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Axogen Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Axogen Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Axogen Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Axogen Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
